Skip to main content
Clinical Trials/NCT00808041
NCT00808041
Completed
N/A

Breast Cancer Chemotherapy Monitoring With Dedicated Breast Computed Tomography

Emory University1 site in 1 country3 target enrollmentJuly 2009
ConditionsBreast Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Emory University
Enrollment
3
Locations
1
Primary Endpoint
Tumor response
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine if dedicated breast computed tomography can be used successfully to monitor tumor response in breast cancer patients undergoing neoadjuvant chemotherapy.

Detailed Description

Before undergoing surgery to remove the tumor, it is common for breast cancer patients to first undergo chemotherapy or hormonal therapy. The main goal of the therapy is to reduce the size of the tumor before it is removed. Unfortunately, therapy response varies a lot between patients. The development of an effective therapy response monitoring method could reduce the time that a patient undergoes ineffectual therapy or unnecessary therapy after complete response. Dedicated breast computed tomography (or breast CT), a new way of imaging the breast, has been introduced in the last few years. Breast CT is an x-ray exam that uses 3D imaging to show the breast in its real three dimensional shape. Combined with the use of special chemicals called iodine contrast enhancement, breast CT can provide images of both the anatomy and the blood flow in the breast. We propose to use breast CT to carefully monitor the response to therapy of breast cancer patients undergoing therapy before surgery.

Registry
clinicaltrials.gov
Start Date
July 2009
End Date
July 2015
Last Updated
10 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ioannis Sechopoulos, Ph.D.

Assistant Professor of Radiology and Imaging Sciences

Emory University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Tumor response

Time Frame: Mid-treatment and post-treatment completion

Study Sites (1)

Loading locations...

Similar Trials